Gene · 7170
Papers3,595
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
721 to 740 of 3,595
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The Molecular Biology of Soft Tissue Sarcomas: Current Knowledge and Future Perspectives. | Cancers (Basel) | 2022 | 35626152 | PubTator, text mining | PubMed |
| Thyroid Cancer Detection in a Routine Clinical Setting: Performance of ACR TI-RADS, FNAC, and Molecular Testing in Prospective Cohort Study. | Biomedicines | 2022 | 35625691 | PubTator, text mining | PubMed |
| The significance of the fusion partner gene genomic neighborhood analysis in translocation-defined tumors. | Mol Genet Genomic Med | 2022 | 35621010 | PubTator, text mining | PubMed |
| Unique SLC12A2-ROS1 fusion is associated with marked response to crizotinib in lung adenocarcinoma. | SAGE Open Med Case Rep | 2022 | 35619747 | PubTator, text mining | PubMed |
| Alectinib versus crizotinib in ALK-positive advanced non-small cell lung cancer and comparison of next-generation TKIs after crizotinib failure: Real-world evidence. | Cancer Med | 2022 | 35616090 | PubTator, text mining | PubMed |
| Delineating the conformational landscape and intrinsic properties of the angiotensin II type 2 receptor using a computational study. | Comput Struct Biotechnol J | 2022 | 35615027 | PubTator, text mining | PubMed |
| A comprehensive evaluation of the potential binding poses of fentanyl and its analogs at the µ-opioid receptor. | Comput Struct Biotechnol J | 2022 | 35615021 | PubTator, text mining | PubMed |
| Failure of crizotinib based systemic treatment in ALK positive histiocytosis involving the central nervous system: a case report and literature review. | BMC Pediatr | 2022 | 35614430 | PubTator, text mining | PubMed |
| Serum proteomics unveil characteristic protein diagnostic biomarkers and signaling pathways in patients with esophageal squamous cell carcinoma. | Clin Proteomics | 2022 | 35610567 | PubTator, text mining | PubMed |
| Structural insights into the ligand binding and Gi coupling of serotonin receptor 5-HT5A. | Cell Discov | 2022 | 35610220 | PubTator, text mining | PubMed |
| Selective Signal Capture from Multidimensional GPCR Outputs with Biased Agonists: Progress Towards Novel Drug Development. | Mol Diagn Ther | 2022 | 35595932 | PubTator, text mining | PubMed |
| Structural insights into galanin receptor signaling. | Proc Natl Acad Sci U S A | 2022 | 35594396 | PubTator, text mining | PubMed |
| Personalized medicine: From diagnostic to adaptive. | Biomed J | 2022 | 35590431 | PubTator, text mining | PubMed |
| Structural basis for inhibition of the Cation-chloride cotransporter NKCC1 by the diuretic drug bumetanide. | Nat Commun | 2022 | 35585053 | PubTator, text mining | PubMed |
| Tumor-derived exosomes: immune properties and clinical application in lung cancer. | Cancer Drug Resist | 2022 | 35582534 | PubTator, text mining | PubMed |
| Structural insights into the HBV receptor and bile acid transporter NTCP. | Nature | 2022 | 35580630 | PubTator, text mining | PubMed |
| A pathogenic mechanism associated with myopathies and structural birth defects involves TPM2-directed myogenesis. | JCI Insight | 2022 | 35579956 | PubTator, text mining | PubMed |
| Ca2+-mediated higher-order assembly of heterodimers in amino acid transport system b0,+ biogenesis and cystinuria. | Nat Commun | 2022 | 35577790 | PubTator, text mining | PubMed |
| EML4-NTRK3 Fusion Cervical Sarcoma: A Case Report and Literature Review. | Front Med (Lausanne) | 2022 | 35572973 | PubTator, text mining | PubMed |
| Molecular insights into ligand recognition and activation of chemokine receptors CCR2 and CCR3. | Cell Discov | 2022 | 35570218 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7170/papers?page=37